Reflections of this month’s JP Morgan Week when many of the Life Sciences world of companies, investors and commentators ...

Cambridge-based Blighter Surveillance Systems, which designs and makes electronic scanning ground surveillance radars, is ...

Railpen, manager of the £34 billion Railways Pension Scheme in the UK, has achieved a BREEAM ‘Outstanding’ design-stage score ...

The life sciences outlook for 2026 is being shaped by three interlocking forces, writes Paul Hughes, Managing Director, Life Sciences & Technology, BDO LLP.

Wellcome Sanger Institute Senior Group Leader, and former Institute Director, Professor Sir Mike Stratton has been awarded the 2026 Jessie Stevenson Kovalenko Medal by the Council of the National ...

The UK biotech sector continues to demonstrate a quiet but determined resilience, even as investors navigate more cautious global market conditions, writes Zickie Lim, Partner and Head of Venture ...

Cambridge company TeraView, a pioneer and leader in terahertz technology and solutions, has become the first UK and probably ...

AstraZeneca has announced plans to invest $15 billion in China to pioneer the next-generation of innovative medicines. CEO ...

Derek Jones, the CEO of Babraham Research Campus in Cambridge, is leaving the business at the end of January. He intended to step down from the role in the summer but agreed a deferment.

Cambridge's fast-growing quantum computing company, Nu Quantum, is set to open a new subsidiary in Spain where founder and CEO Dr Carmen Palacios‑Berraquero was born and raised.

France-gated Verlingue has acquired Cambridge-based Employee Benefits and Financial Planning specialist, EBCam, marking an important step in its continued expansion in the UK market. No figures for ...

Five banking giants have together pledged to inject £11 billion into helping UK companies scale here and overseas.